Aug 2 |
Q2 2024 Ionis Pharmaceuticals Inc Earnings Call
|
Aug 1 |
Q2 2024 Paysign Inc Earnings Call
|
Jul 30 |
AstraZeneca reports positive data from chronic lymphocytic leukaemia therapy trial
|
Jul 30 |
NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu for NHS
|
Jul 29 |
Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
|
Jul 28 |
AstraZeneca (LON:AZN) Has Announced A Dividend Of $0.776
|
Jul 27 |
AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Jul 26 |
FDA committee proposes overhaul of perioperative lung cancer trials
|
Jul 26 |
3 Surprisingly Underrated Stocks to Buy Right Now
|
Jul 26 |
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|